Equities

Create Medic Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
5187:TYO

Create Medic Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,141.00
  • Today's Change6.00 / 0.53%
  • Shares traded6.90k
  • 1 Year change+23.75%
  • Beta0.3188
Data delayed at least 15 minutes, as of Feb 18 2026 04:21 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CREATE MEDIC CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical devices. Its main products include urinary drainage, such as transurethral and nephrostomy; PEG related products; endoscopic products, such as esophagus and stomach; intestinal treatment-devices, such as small intestine and large intestine; anesthesiology products, such as endotracheal tubes and tracheostomy tubes, IVR devices, among others products.

  • Revenue in JPY (TTM)13.62bn
  • Net income in JPY713.73m
  • Incorporated1974
  • Employees1.00k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Leoclan Co Ltd28.69bn237.07m5.52bn155.0023.551.0112.420.192439.5839.584,841.68922.241.8734.116.11185,101,400.001.672.342.934.7813.1411.260.89321.201.4149.670.480934.118.51-0.465612.294.8012.954.98
Data Horizon Co Ltd5.18bn-2.30bn6.14bn367.00--20.34--1.19-181.31-181.31407.7923.740.746621.802.4414,102,500.00-33.20---54.27--36.77---44.47--1.29-3.050.9424--------------
Precision System Science Co Ltd5.03bn-35.13m6.64bn151.00--1.7135.911.32-1.28-1.28184.10140.030.89592.265.9233,309,860.00-0.6257-4.14-0.8672-5.5530.2630.20-0.6984-6.051.521.910.1787--17.91-1.5277.43---25.44--
Aso International Inc3.95bn473.61m7.01bn310.0015.062.3813.591.7747.4947.49396.47300.461.1916.337.9512,754,750.0014.20--16.71--44.89--11.98--4.7031.510.00--7.10--13.50------
Yamashita Health Care Holdings Inc63.77bn412.00m9.09bn613.0021.470.995514.200.1425165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Koken Ltd11.86bn885.29m9.84bn321.0010.720.68717.560.8299179.77179.772,408.462,805.840.54762.482.30--4.093.905.214.9545.4045.897.477.411.6823.740.295719.1510.173.1522.611.11-11.116.96
Kainos Laboratories Inc5.46bn597.66m10.38bn157.0016.061.3514.861.90141.77141.771,294.101,688.390.61923.033.0734,748,430.006.787.128.129.3248.0951.5710.9611.493.45--0.071721.114.932.850.47879.976.9016.36
Create Medic Co Ltd13.62bn713.73m10.83bn1.00k13.750.57558.440.795681.5281.521,540.661,947.780.67761.814.29--3.553.014.073.5244.0244.005.244.514.8135.350.043959.804.514.69-15.121.591.663.99
JMS Co Ltd66.09bn-224.00m10.91bn5.47k--0.25894.550.165-9.15-9.152,695.911,703.210.76512.443.5412,084,290.00-0.36580.7427-0.53821.1022.7723.52-0.47810.88361.076.050.393671.626.833.56347.22-46.21-1.640.00
JTEC Corp2.01bn90.61m12.07bn76.00132.824.5447.766.0115.3915.39340.67449.750.58771.5811.3526,411,460.002.651.763.021.9962.1059.574.513.782.4875.980.1480.00-4.2213.39-69.7629.84-17.34--
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.03bn538.00--0.516124.120.5299-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
OLBA Healthcare Holdings Inc124.52bn1.23bn13.23bn1.39k10.171.036.860.1062208.00208.0021,012.962,050.242.6215.184.4989,389,400.002.603.438.3111.3911.2711.490.98981.220.966350.240.231830.513.492.61-4.6834.3828.7114.87
DVx Inc55.33bn308.75m13.25bn334.0041.711.4812.260.239429.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
Daiken Medical Co Ltd10.17bn981.12m15.25bn180.0014.031.7912.421.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Seed Co Ltd33.57bn1.17bn16.16bn985.0013.780.873.640.481538.7638.761,109.07613.830.642.357.4334,078,080.002.222.313.583.9445.1242.203.473.300.59286.620.575736.012.580.8892-44.3833.9912.644.56
Data as of Feb 18 2026. Currency figures normalised to Create Medic Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

0.25%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 30 Nov 20258.80k0.09%
Acadian Asset Management LLCas of 31 Jan 20265.68k0.06%
Dimensional Fund Advisors Ltd.as of 30 Nov 20255.40k0.06%
LSV Asset Managementas of 31 Jan 20262.78k0.03%
Amova Asset Management Co., Ltd.as of 31 May 2024600.000.01%
State Street Global Advisors (Japan) Co. Ltd.as of 05 Mar 2024600.000.01%
Nomura Asset Management Co., Ltd.as of 29 Sep 2025200.000.00%
Resona Asset Management Co., Ltd.as of 10 Dec 2024100.000.00%
Tokio Marine Asset Management Co., Ltd.as of 20 Jun 20250.000.00%
Mitsubishi UFJ Asset Management Co., Ltd.as of 14 Mar 20240.000.00%
More ▼
Data from 19 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.